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1PART I
2I ABBREVIATIONS
ATT - Anti Tuberculous Treatment
CMV - Cyto Megalo Virus
BD - Bi Daily
OD - Once Daily
AIDS - Acquired Immuno Deficiency Syndrome
IRVAN - Idiopathic Retinal Vasculitis, Aneurysms And Neuroretinitis
DUSN - Diffuse Unilateral Subacute Neuroretinitis
OCT - Optical Coherence Tomography
SD-OCT - Spectral Domain Optical Coherence Tomography
LED - Light Emitting Diode
RPE - Retinal Pigment Epitheum
NFL - Nerve Fibre Layer
OPD - Out Patient Department
TC - Total Count
DC - Differential Count
ESR -  Erythrocyte Sedimentation Rate
3TORCH   - Toxoplasmosis, Rubella, Cyto Megalo Virus, Herpes
VDRL      - Venereal Disease Research Laboratory
ELISA      -     Enzyme Linked Immuno Sorbent Assay
HIV          -     Human Immunodeficiency Virus
BP            -     Blood Pressure
RBS         -     Random Blood Sugar
BCVA     -     Best Corrected Visual Acuity
SRF         -     Sub Retinal Fluid
 SRD        -     Serous Retinal Detachment
NCT        -   Non Contact Tonometer
CSF            - Cerebro Spinal Fluid
ENT - Ear Nose Throat
AION - Anterior Ischemic Optic Neuropathy
BRVO - Branch retinal vein occlusion
CRVO - Central retinal vein occlusion
FTA-ABS - Flourescent Treponema  Pallidum Antibody Absorption Test
VEP - Visually Evoked Potential
4INTRODUCTION
Neuroretinitis is a form of optic neuropathy characterized by acute
unilateral visual loss in the setting of optic disc swelling and hard exudates
arranged in a star figure around the fovea.1 It affects persons of all ages, although
it occurs more often in the third and fourth decades of life, with no gender
predilection. 2 , 3  It is mostly unilateral and may be precipitated by various known
and unknown factors.
Neuroretinitis is a rare clinical entity often confused with the more
common papillitis or papilledema. The fundus pictures have several common
features and can be mistaken for one another by ill-experienced clinicians and
sometimes even by ophthalmologists and neurologists.
However, there are certain diagnostic features distinctive for neuroretinitis.
It is a distinct clinical entity with a different etiopathogenesis. Likewise its
management and prognosis too differs from fundoscopically similar entities
encountered more often in our clinical practice.
ANATOMY OF OPTIC NERVE HEAD
Optic disc is the water-shed zone between retina and optic nerve. It is the
exit site of all ganglion cell axons of the retina, which converge at the optic disc
to leave the eye and form the optic nerve.
5The optic disc is located in the nasal retina 3-4 mm from fovea. It is
1.8mm in vertical diameter and 1.5 mm in horizontal diameter. Since there are no
photo receptors over the disc, it is projected in visual space as an absolute
scotoma, “The Blind spot of mariotte”. The blind spot is centered 150 from
fixation and slightly below the horizontal meridian in the temporal visual field. It
represents 70/50 in  the visual space.
The optic nerves are surrounded by meningeal sheaths, dura, arachonid and
pia matter upto lamina cribrosa. There is extension of the intracranial
subarachnoid space forward around the optic nerve to the back of the eye ball.
Blood supply
Surface area is supplied by retinal capillaries.
Pre laminar region is supplied by peripapillary chorioidal vessels.
Laminar portion of optic nerve head receives its blood supply from circle of
Zinn, formed by short ciliary vessels.
Post laminar area is supplied by branches of pial plexus from central rential
artery.
6Fig.1   Blood Supply Of Optic Nerve Head
ANATOMY OF MACULA
The umbo, foveola, fovea, parafovea and perifovea together constitute the
macula or the central area. The central area can be differentiated from the extra-
areal periphery by the ganglion cell layer. In the macula, the ganglion cell layer is
several cells thick, while in the extra-areal periphery it is only 1 cell thick. The
macular border coincides with the course of the major temporal arcades and has
an approximate diameter of 5.5mm
PARAMETERS OF MACULA
a) Diameter of fovea- 1.5 mm.
b) Diameter of parafovea- 1 mm.
c) Diameter of perifovea- 3mm.
71. UMBO
It is a tiny depression in the very center of the foveola which corresponds
to the ophthalmoscopically visible foveal reflex.
2. FOVEOLA (350microns-0.35mm)
It is a small central region in which the thickness of retina is reduced so as
to contain only photoreceptors, glial cells and muller cells.
3. FOVEAL AVASCULAR ZONE (FAZ-800microns-0.8mm)
It is located inside fovea but outside the foveola.
4. FOVEA (1500microns-1.5mm)
It is a small depression where the retina is reduced to half its normal
thickness. Moving towards the centre of retina the inner nuclear layer is reduced
to a double row of cells at edge of fovea.
Fig 2 Anatomy of Macula
8HISTOLOGY OF MACULA:
Retina at the macula consists of 3 types of cells and their synapses
arranged from without inwards in the following layers,
Retinal pigment epithelium
Layer of Rods and Cones
External limiting membrane
Outer nuclear layer
Outer plexiform layer
Inner nuclear layer
Inner plexiform layer
Ganglion cell layer
Nerve fibre layer
External limiting membrane
Fig 3.Histology of Macula
9MACULAR FUNCTION TESTS
These are required for diagnosing as well as for following up of macular
diseases and for evaluating the potential macular function in eyes with opaque
media like in cataract, dense vitreous haemorrhage.
The retinal function testing can be divided into PSYCHOPHYSICAL and
PHYSIOLOGICAL methods.
A Psychophysical test is subjective. A physical stimulus is presented to the
patient and the patient indicates verbally or by other subjective means his
detection of the stimulus.
Physiologic methods are objective. A stimulus is presented and a response
parameter is measured by electro-physiological or other means.
PSYCHOPHYSICAL TESTS
1. Visual Acuity.
2.  Pupillary Reaction.
3.  Photostress test.
4.  Amslers grid.
5.  Two point discrimination test.
6.  Entoptic phenomenon.
7.  Tests dependent on macular pigment.
8.  Maddox rod test.
9.  Colour vision.
10.  Foveal flicker sensitivity.
11.  Grating psychophysics.
12.  Dark adaptation.
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13.  Perimetry.
14.  Laser interferometry.
15.  Potential acuity meter.
16.  Haidinger’s brushes.
17.  Maxwell’s spot.
18.  Koch’s yellow filter test.
ELECTROPHYSIOLOGICAL TEST’S
1.  Electroretinography (ERG).
2.  Electrooculograhy (EOG).
3.  Visually evoked response (VER).
AETIOLOGY OF NEURORETINITIS
Neuroretinitis is thought to be an infectious or immune mediated process
that may be precipitated by a number of different agents. The common infections
that cause neuroretinitis are cat-scratch disease, spirochetes especially syphilis8,
lyme disease, and leptospirosis2. Cat-scratch disease accounts for one third of
infectious cases9,10. Additional causes include toxoplasmosis11, mumps12,
salmonella13, tuberculosis14 and histoplasmosis. Despite thorough evaluation,
approximately one half of cases remain idiopathic.
                      Neuroretinitis is commonly associated with an antecedent viral
syndrome, suggesting a possible viral etiology in up to 50% of the cases; however
viruses are rarely cultured from the CSF of such patients and serological evidence
of a concomitant viral infection is usually lacking.
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I. Infectious
1. Viruses-
i. Herpes simplex
ii. Hepatitis B
iii. Mumps
iv. Herpes Zoster
v. HIV
vi. HBV
2. Parasites-
i. Toxoplasma,
ii. Toxocara
3. Fungi-
i. Histoplasmosis
4. Bacteria-
i. Syphilis
ii. Leptospirosis
iii. Cat scratch disease
iv. Lyme disease
v. Tuberculosis
vi. Salmonella
II. Parainfectious (Immune mediated)
III. Idiopathic (Leber’s stellate neuroretinitis)
Cat scratch disease
Cat-scratch disease, a systemic infection caused by the pleomorphic gram-
negative bacillus Bartonella henselae, is the most common infectious process
associated with neuroretinitis.
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Patients present following cat exposure with fever, malaise, headache, eye
pain and blurred vision. Examination typically reveals local lymphadenopathy.
Some patients also have symptoms of arthritis, hepatitis, meningitis, or
encephalitis.
Decreased visual acuity (ranging from 20/40 to counting fingers) is often
associated with dyschromatopsia and afferent pupillary defect. Ophthalmoscopic
findings include neuroretinitis, cottonwool spots, multiple discrete lesions in the
deep retina, and stellate macular exudates.
B. henselae infection is confirmed with positive blood cultures or elevated
immunofluorescent antibody titers or both. Therapy is aimed to promote
resolution of neuroretinitis, restoration of visual acuity, and clearance of
bacteremia9. Electrophysiologic studies show that when compared to the fellow
eye, affected eyes have subnormal contrast sensitivity, abnormal color vision, and
abnormal visually evoked potentials. However ERG may be normal. Recently
polymerase chain reaction has been found to be a valuable method of diagnosing
cat-scratch disease when serology is considered negative or borderline17.
AIDS-associated CSD neuroretinitis may additionally have conjunctival
and retinal bacillary angiomatosis. Although a self-limiting disorder, systemic
corticosteroids with or without systemic antibiotics have been reported to be
effective in this condition. 16 Azithromycin, ciprofloxacin, rifampicin, parenteral
gentamicin, or trimethoprim-sulfamethoxazole has been found to be effective in
immunocompromised patients.
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Lyme disease
Neuroretinitis in Lyme disease may be unilateral or bilateral, but when
bilateral is usually simultaneous and symmetric18. The patients usually live or
work in an endemic area and may give a history of a tick bite within the last 6
months.
They often have cutaneous, cardiac and neurological manifestations.
Cardiac manifestations include atrioventricular block, myocarditis,
cardiomyopathy, and pericarditis. Neurological manifestations include meningitis,
myelitis, encephalitis, cranial and peripheral neuropathies.
Although ocular manifestations of Lyme disease have long been noted,
they remain a rare feature of the disease. The spirochete invades the eye early
and remains dormant, accounting for both early and late ocular manifestations. A
nonspecific follicular conjunctivitis occurs in approximately 10% of patients with
early Lyme disease. Keratitis is characterized by nummular non-staining
opacities. Inflammatory syndromes such as vitritis and uveitis, have been
reported; in some cases, a vitreous tap is required for diagnosis. Neuro-
ophthalmic manifestations include neuroretinitis, multiple cranial nerves
involvement and optic atrophy.
Criteria for establishing that eye findings can be attributed to Lyme disease
include the lack of evidence of other disease, other clinical findings consistent
with Lyme disease, occurrence in patients living in an endemic area, positive
14
serology, and in most cases, response to treatment. Management of ocular
manifestations often requires intravenous therapy18.
Leber’s stellate retinopathy
When there is no proven etiology to the disease, a diagnosis of Leber’s
idiopathic stellate retinopathy is made19. Thus it is a diagnosis of exclusion made
after other known causes of neuroretinitis are ruled out.
It usually affects children or young adults. This diagnosis is mostly not
assigned to patients aged more than 50 years until treatable causes of
neuroretinitis or a macular star have been excluded. Most cases are unilateral. The
incidence is equal in both sexes.
Patients present with acute loss of vision with or without ocular pain. A
nonspecific viral illness precedes or accompanies the visual loss. Presenting
visual acuity may be 20/20 to LP. But, most cases are in the 20/40 to 20/200
range.
In children, Leber’s neuroretinitis must be distinguished from anterior
optic neuritis and papillitis, since multiple sclerosis occasionally develops in
children with these diseases20. A distinguishing feature is the development of
macular star. In Leber’s disease, the target tissue as suggested by Gass 21 is
vascular whereas in anterior optic neuritis caused by demyelinating disease, the
target tissue is primarily neural. Leber’s neuroretinitis usually resolves without
treatment within 6-12 weeks19. However the macular star may persist beyond this
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period. Most patients recover good visual acuity with over 90% returning to 20/50
or better. Recurrences are very rare although in bilateral cases, involvement of the
fellow eye may follow the first. Fluorescein study demonstrates intense
hyperfluorescence due to leakage from capillaries within the disc. There is no
leakage from the retinal vessels in the macula.
Idiopathic retinal vasculitis aneurysms and neuroretinitis (IRVAN)
IRVAN syndrome is the acronym for idiopathic retinal vasculitis,
aneurysms and neuroretinitis. This syndrome typically affects young, healthy
individuals; it has a female predominance, is usually bilateral and is not
associated with any systemic abnormalities.
The most characteristic feature is the presence of macroaneurysms seen as
dilatations of the retinal and optic nerve head arterioles. Exudative retinopathy
and capillary nonperfusion is usually seen adjacent to retinal and optic nerve head
aneurysms and is concentrated in the peripapillary location. This condition is not
a true neuroretinitis as there is no clinically evident neuropathy but only late
diffuse staining of the optic nerve head due to local vascular changes. There is
little role of steroids and panretinal photocoagulation is advocated if retinal
neovascularisation occurs22.
Diffuse unilateral subacute neuroretinitis (DUSN)
DUSN is a progressive parasitic disease affecting the outer retina and
retinal pigment epithelium (RPE). This syndrome is primarily unilateral, although
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bilateral cases have occurred. The ocular findings include visual loss, vitreous
cells, optic disc inflammation and leakage, transient recurrent crops of gray-white
outer retinal lesions23. Stationary or migrating nematodes have been identified
deep in the retina or in the subretinal space. DUSN is a condition in which prompt
identification and destruction of the infecting nematode can result in the cessation
of symptoms and the preservation of good visual acuity. If untreated, the disease
progressively damages the retina and the optic nerve leading to severe visual loss.
Laser photocoagulation of the nematode is the treatment of choice24.Visual acuity
may not improve significantly unless the worm is killed soon after onset of visual
loss.
It has been found that thiabendazole is effective in the treatment of some
patients when the worm cannot be found and when DUSN is accompanied by a
moderate degree of vitritis that is associated with a breakdown in the blood-
retinal barrier.25 However antihelminthics have not been found to be that effective
in confirmed cases of DUSN26. Regardless of the nature of the causative
nematode, DUSN should always be suspected in healthy patients with unilateral
ocular signs of persistent vitritis associated with papillitis, retinal vasculitis, and
multifocal lesions involving the outer retinal layers.
Mutiple sclerosis
Multiple sclerosis is one condition that is not associated with
neuroretinitis2. It is a well known fact that patients who develop typical optic
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neuritis are prone to develop multiple sclerosis but there is no similar increased
tendency for patients who experience an attack of neuroretinitis27. Thus, when a
diagnosis of an attack of acute optic neuropathy as an episode of neuroretinitis
rather than anterior optic neuritis is made, it substantially alters the neurologic
prognosis in the patient being evaluated. Nevertheless, there have been anecdotal
reports of patients with multiple sclerosis who developed neuroretinitis 28.
PATHOLOGY OF NEURORETINITIS
The pathogenesis of neuroretinitis is associated with the direct
involvement of the optic nerve fibres by the infectious process or the
inflammation leading to edema and fluid exudation from the inflamed cellular
area of the peripapillary retina. Since macular exudates result more likely from
the primary optic nerve disease, rather than from the inflammation of the retina,
the idiopathic variety is also called as 'idiopathic optic disc edema with a macular
star' rather than 'neuroretinitis'. [6] There is abnormal permeability of capillaries
deep within the optic disc, with no abnormality of retinal vasculature. This results
in leakage of lipid-rich exudates into the adjacent subretinal space and outer
plexiform layer. With reabsorption of serum, lipid precipitates in a stellate
pattern. When optic disc swelling and macular star are associated with focal or
multifocal inflammatory lesions in the retina (retinitis), especially if an infectious
cause is documented, the term neuroretinitis is doubtful. The macular exudates
may not develop until two weeks after the onset; hence, the need to reexamine
patients with acute papillitis with a normal macula within two weeks for
development of macular star figure.
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CLINICAL FEATURES
The clinical picture of neuroretinitis is characteristic and clinically distinct
from other optic neuropathies.
 The condition is usually painless but some patients complain of eye pain
that may worsen with eye movements as seen in optic neuritis.If the neuroretinitis
is due to an infectious process, there may be associated fever, malaise or
headache.
Visual acuity at presentation can range from 20/20 to light perception. The
degree of colour deficit is usually worse than the degree of visual loss would
suggest.
 The most common field defect is a cecocentral scotoma, but central
scotomas, arcuate defects, and even altitudinal defects may be present. A relative
afferent pupillary defect is present in most patients, unless the condition is
bilateral. This is indicative of optic disc involvement. Absence of afferent
pupillary defect indicates a primary macular involvement4. The degree of optic
disc swelling ranges from mild to severe, depending in part on the timing of the
first examination. In severe cases, splinter hemorrhages may be present.
Segmental disc swelling has been reported.
A macular star figure composed of lipid (hard exudates) may not be
present when the patient is examined soon after visual symptoms begin, but tends
to become more prominent as the optic disc swelling resolves5. Small, discrete,
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usually white, chorioretinal lesions may occur in both the symptomatic and
asymptomatic eyes6.
Posterior inflammatory signs consisting of vitreous cells and venous
sheathing as well as occasional cells and flare may occur.
INVESTIGATIONS TO DETERMINE THE ETIOLOGY OF
NEURORETINITIS
Ocular
1. Color vision,
2. Contrast sensitivity
3. Amslers grid
4. Fluorescein angiography
5. VEP
Systemic
1. Blood culture-cat scratch disease
2. VDRL and FTA-ABS- Syphilis
3. Viral serology
4. Mantoux , chest X ray
5. ESR
6. Lumbar Puncture- opening pressure, cells, proteins, glucose,
7. CSF culture for bacteria especially leptospirosis and fungi
8. Immunofluorescent antibody test- cat scratch disease
9. ELISA- Toxoplasmosis, Toxocariasis
10. Polymerase chain reaction- cat scratch disease
11. Neuroimaging
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DIFFERENTIAL DIAGNOSIS
1. AION
2. Hypertensive retinopathy
3. BRVO/CRVO,  rarely papillophlebitis
4. Papilledema
5. Compressive optic neuropathy
6. Infiltrative optic neuropathy
7. Nonspecific uveitis
TREATMENT
Treatment of neuroretinitis depends on whether there is an underlying
infectious or inflammatory condition that requires therapy. No treatment is
required in the idiopathic group as the disease is self-limiting.
Cat-scratch disease is usually described as a benign, self-limited illness30.
Patients with neuroretinitis associated with cat scratch disease have been treated
with prednisolone, dexamethasone, clindamycin, ciprofloxacin, trimethoprim-
sulfa, or tetracycline and all had improved vision.31,32 Doxycycline and rifampicin
appear to shorten the course of disease and hasten visual recovery. Long-term
prognosis is good, but some individuals may acquire a mild postinfectious optic
neuropathy.
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Patients with neuroretinitis and secondary or late syphilis should be treated
with intravenous penicillin, and patients with Lyme disease should also be treated
with an appropriate antibiotic such as ceftriaxone, amoxycillin, or tetracycline.
Though systemic steroids have been tried, there is no definite evidence that such
treatment alters either the speed of recovery or the ultimate outcome.19 The
prognosis in most cases of idiopathic neuroretinitis is excellent as it is self
limiting.
CLINICAL COURSE:
Neuroretinitis is usually a self-limited disorder with a good visual
prognosis.
Typically over 6 to 8 weeks, the optic disc swelling resolves and the
appearance of the disc becomes normal or mildly pale.
The macular exudates appear late and progress over about 7 to 10 days,
then remain stable for several weeks before gradual resolution occurs over 6 to 12
months.
Most patients ultimately recover good visual acuity, although some
complain of persistent metamorphosia or nonspecific blurred vision from mild
disruption of the macular architecture.
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Most patients do not experience a subsequent attack in the same eye, and
only a few patients develop a similar attack in the fellow eye.
Recurrent Idiopathic Neuroretinitis is an uncommon condition in which
repeated acute episodes lead to progressive and permanent visual loss4. This
disorder usually affects young adults and has no predilection with regard to sex.
The interval between attacks is quite variable ranging from 1 month to 9.8 years.
Treatment of the acute attack with either oral or intravenous corticosteroids has
not appeared to alter the visual prognosis of this condition. Although the cause of
recurrent idiopathic neuro retinitis has not been elucidated, an autoimmune
disorder has been proposed that involves occlusive vasculitis affecting the optic
disc. Long-term immunosuppression has been tried in some of these patients.
OPTICAL COHERENCE TOMOGRAPHY
Optical Coherence Tomography is a new diagnostic tool that can perform
tomography or cross – sectional imaging of biological tissues with ?10 microns
axial resolution using light waves.
Principle:
It uses infrared light. The speed of light is almost a million times faster
than sound and this difference allows the measurement of structures with
resolution of ? 10 microns compared to 100 micron scale of ultrasound.
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Ultrasound needs contact with the tissue under study, whereas OCT does
not require any contact.
It is a non contact, non – invasive device where a broad band width of near
infra –red light beam (820nm) is projected on to the retina. The light gets
reflected from the boundaries between the microstructure and also gets scattered
differently from tissues with different optical properties. It then compares the
echo time delay of the same wavelength that is reflected from a reference mirror
at a known distance.
Optical coherence tomography uses, low coherence or white light
interferometry to perform high resolution measurements and imaging.
An optical beam from a laser or light source which emits short optical
pulses or short coherence length light is directed onto a partially reflecting mirror
(optical beam splitter). The partially reflecting mirror splits the light into two
beams, one beam is reflected and the other is transmitted. One light beam is
directed on to the patient’s eye and is reflected from intraocular structures at
different distances. The reflected light beam from the patient’s eye consists of
multiple echoes which give information about the range or distance and thickness
of different intra-ocular structures. The second beam is reflected from a reference
mirror at a known spatial position. This retro-reflected reference optical beam
travels, back to the partial mirror (beam splitter) where it combines into the
optical beam reflected from the patient’s eye.
24
When the two light pulses co-incide they produce a phenomenon known as
interference which is measured by a light sensitive detector (photodetector). Thus
the interferometer can precisely measure the echo structure of reflected light and
perform high resolution measurements of the distance and thickness of different
tissue structures. The key feature of interferometer is that it can measure the time
delay of optical echoes by comparing the reflected light beam with a reference
beam. While the explanation presented here assumes that the light is composed of
short optical pulses, the measurement may also be performed using non-pulsed or
continuous light with a short coherence length. For this reason, the measurement
technique has been termed ‘low coherence interferometer’.
           The light source for the interferometer is a compact super luminescent
diode, which is coupled directly into an optical fiber. This light source is similar
to laser diode used in optical compact disc players, except in OCT, the diode
source is designed to emit short coherence length light. The interferometer is
constructed using a fiber optic coupler which functions, analogous to a beam
splitter. The arm of the interferometer which consists of reference mirror is
located within the instrument, while the optical fiber in the second arm of the
interferometer is connected to the OCT ophthalmic instrument resembling a slit
lamp biomicroscope or fundus camera.
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Fig 4. Schematic diagram of the fiber-optic interferometer and imaging
optics comprising the optical coherence tomographic scanner.
Image resolution
The image resolution of OCT in the axial (or longitudinal) verses transverse
directions is determined by different mechanisms. The resolution of the image in
the axial (longitudinal) direction is determined by the resolution of the optical
ranging measurement. This is determined by the physical properties of light
source which is used for the measurement. If a short pulse laser source is used,
the axial resolution is determined by the pulse duration. Conversely, if a
continuous, low-coherence light source is used, the axial resolution is determined
by the ‘coherence length’ of the light source. It is important to note that the
measurement of distance or tissue thickness can, in practice, be performed with
significantly higher resolution than this limit.
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                  The transverse resolution of the image is determined by the size of the
focused optical beam. This is a function of the optics used to project the beam
onto the eye and this is determined by factors such as whether imaging is
performed over a large depth, such as in the anterior eye, or whether the focusing
angle is restricted, as in imaging the retina. The image resolution is also a
function of the size of the tomogram that is desired.
OCT Scan Protocols in Macula
The protocols that are helpful in macular diseases are the following ;
(i)  Line Scan
The line scan gives an option of acquiring multiple line scan without
returning to main window. The length of the line scan and the angle can be
altered, though one has to keep in mind that as the scan length increases the
resolution decreases.
(ii)  Radial Lines
The scan protocol consists of 6 -24 equally spaced line scans that can be
varied in size and parameters. All the lines pass through a central common axis.
The radial lines are useful for acquiring macular scan and retinal thickness /
volume analysis.
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(iii)  Macular thickness map
This is the same as radial lines except that the aiming circle has a fixed,
diameter of 6mm. This helps in measuring the retinal thickness.
(iv)  Fast macular thickness map
It is designed for use with retinal thickness analysis. When done in both
the eyes, it can be used for comparative retinal thickness / volume analysis. It is a
quick protocol that takes only 1.95 sec to acquire six scans of 6mm length each.
(v) Raster Line
This provides an option of acquiring series of line scans that are parallel,
equally spaced and are 6 – 24 in number. These multiple lines scans are placed
over rectangular regions, the area of which can be adjusted so as to cover the
entire area of pathology. This is especially useful in conditions like choroidal neo-
vascular membrane one wishes to obtain scans at multiple levels.
(vi) Repeat:
Repeat protocol enables one to repeat any of the previously saved
protocols using same set of parameters, which includes scan size, angle,
placement of fixation, light emitting diode (LED) and landmark.
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Normal macular scan
On a 10mm horizontal line scan passing through the foveal centre, one can
clearly demarcate two major landmarks namely optic disc and fovea.
1.  The optic disc is seen towards the right of the tomogram and is easily
identifiable by its contour.
2.  The central depression represents the optic head cup and the stalk
continuing behind is the anterior part of the optic nerve.
3.  The fovea is seen to the left and is easily identifiable by the characteristic
thinning of retinal layers.
4.  The vitreous anterior to the retina is non-reflective and is seen as a dark
space.
5.  The interface between the non – reflective vitreous and back scattering
retinal layers is the vitreo-retinal interface.
6.  The retinal nerve fiber layer is highly reflective and increases in thickness
towards the optic nerve.
7.  The posterior boundary of the retina is marked by a hyper – reflective layer
that represents retinal pigment epithelium(RPE) and chorio capillaries.
8.  Just anterior to RPE – chorio-capillaries complex is a minimally reflective
layer that represents photoreceptors.
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9.  Above this layer of photoreceptors are alternating layers of moderate and
low reflectivity that represents different layers of neuro-sensory retina.
10.  The retinal blood vessels within the neuro-sensory retina shows back
scatter and also cast a shadow behind.
Image Interpretation:
OCT displays the tomograms in real time using a false colour code scale
that represents the degree of light back scattering from tissues at different depths
in the retina.
COLOUR CODES:
Blue, Black (dark colours) - regions of minimum relative optical reflectivity.
Red, White (bright colours)- regions of high optical reflectivity.
Deeper choroid and sclera represented as weak reflections due to signal
attenuation.
Retinal pigment epithelium (RPE) and chorio-capillaries are seen as high
reflective red layer.
Dark layer immediately anterior to retinal pigment epithelium is the photo
receptor layer.
Middle retinal layer exhibits moderate back scattering.
Nerve fiber layer (NFL) is highly reflective and inner most.
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Vitreo retinal interface is well defined due to contrast between NFL and non
reflective vitreous.
Hyper – reflective lesions are:
Hard exudates: Seen as hyper – reflective shadows in the neuro-sensory retina
that completely blocks the reflections from the underlying retina.
Blood: Blood causes increasing scattering. Small to thin hemorrhages are seen as
hyper reflective lesions .Thick hemorrhages blocks the reflections from the
underlying structure.
Scars: All fibrotic lesions including disciform scars, choroidal rupture scars,
healed choroiditis etc are hyper – reflective.
Hypo – reflective lesions are:
a) Serous fluid:
Retinal edema is the commonest cause of reduced back scattering and one
can actually point out the site of fluid accumulation. The serous fluid that is
devoid of any particular matter produces an optically empty space with no back
scattering.
b) Hypo – pigmented lesions of RPE.
Advantages of OCT over FFA
? Non contract, non invasive
? Time saving technique
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? Totally avoids mild complications like nausea to life threatening hyper-
sensitivity reactions seen in FFA.
? Measurement of retinal thickness by OCT correlates more strongly with visual
acuity than the presence of leakage on angiography.
? OCT is effective and superior to FFA in demonstrating axial distribution of
fluid.
? Can be repeated as many times needed.
? Can quantitatively assess retinal thickness and demonstrate any associated
RPE structural anomalies.
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PART II
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AIMS AND OBJECTIVES
1. To correlate the visual outcome with macular (OCT) thickness and
reduction of hard exudates (fundoscopy).
2. To find the cause of neuroretinitis.
3. To assess the improvement of visual acuity with treatment.
4. To describe the morphological features of neuroretinitis based on Optical
Coherence Tomography.
5. To assess the cause in case of poor vision.
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MATERIALS AND METHODS
Subject Selection: All new cases attending Ophthal OPD diagnosed with
neuroretinitis in the period of 2 years (June 2009 and June 2011).
Inclusion Criteria:
1. All patients with defective vision due to neuroretinitis of infectious or
inflammatory origin.
2.  Patients of all age groups
Exclusion Criteria:
1.  Associated retinal pathologies
2.  Recurrent neuroretinitis
3. Hypertensive and diabetic retinopathy
All patients presenting with defective vision and fundus examination
showing papillitis with macular star were investigated to rule out infectious
etiology. Diabetic, hypertensive retinopathy and other fundus pathologies were
ruled out.
                Visual acuity, colour vision, pupillary assessment, visual field
examination including amslers test, detailed fundus examination and
investigations like TC, DC, ESR, TORCH screening,VDRL, ELISA for HIV,
Mantoux test,chest Xray , BP,RBS were done.
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Patients with idiopathic etiology were given intravenous bolus steroids
(Methyl Prednisolone 500 mg twice daily for 3 days) and either
Tab. Ciprofloxacin 500mg BD or Cap. Doxycycline 100 mg OD for 14
days.
In case of tuberculosis patient was started on ATT followed by tab.
prednisolone 1mg/kg/day was given.
Toxoplasmos was treated with oral steroids undercover of antibiotics.
CMV neuroretinitis was treated with intravenous acyclovir 500mg, 8th
hourly for a period of 2 weeks.
Screening procedures at presentation and on each visit:
           Visual acuity (BCVA)
           Pupillary assessment
           Colour vision
           Visual fields
           Fundus examination
           Fundus photograph
           Optical Coherence Tomography
Optical Coherence Tomography analysis of macular thickness was done
using SD-OCT. Line scan and macular thickness map was done. The correlation
of visual acuity with resolution of hard exudates on fundus examination and the
corresponding reduction of macular thickness by OCT were analysed.
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RESULTS
In this prospective observational study 22 eyes of 20 patients with
neuroretinitis was included based on the inclusion and exclusion criteria.
AGE DISTRIBUTION OF CASES
In our study the minimum age of presentation was 7 years and maximum
age of 57 years with mean value of 33.55years (Table-1).
Table-1
AGE MINIMUM MAXIMUM MEAN
0-60 7 57 33.55
Table-2
Age (years) Frequency Percent
Upto 10 1 5
11-20 1 5
21-30 3 15
31-40 12 60
41-50 2 10
51-60 1 5
Total 20 100
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Regarding age distribution of cases 60% of patients belonged to
31-40 years, 15% in 21-30 years and 10% in 41-50 years and 5% each in rest of
the groups (table -2).
Sex Distribution
Table -3
Sex FREQUENCY PERCENT
Male 9 45
Female 9 45
Children 2 10
Total 20 100
In our study males and females were affected equally (45% of cases),
children in 2 cases (10%). (Table-3).
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Laterality
Table -4
Eye Frequency Percent
RE 9 45
LE 9 45
Bilateral 2 10
Total 20 100
In our study the numbers of eyes affected were 45% each for right and left
eye. Bilateral involvement is seen in 10% of cases (Table-4).
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Case 9
 Fig 5 a,b  Fundus photograph of case 9 showing bilateral neuroretinitis
Fig 6 a,b Fundus  pictures taken at 4 weeks follow up showing resolution of
disc edema  and hard exudates at macula.
5 a 5 b
6 a 6 b
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Etiology
Table-5
Etiology Frequency Percent
Idiopathic 14 70
Toxo 2 10
CMV 1 5
TB 3 15
Total 20 100
CHART - 4
Regarding the etiology 14 cases (70%) were idiopathic, 2 patients (10%)
were positive for toxoplasmosis, 3 patients (15%) positive for tuberculosis, 1
patient (5%) for cytomegalo virus (Table -5 ).
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Fig 7.  photograph of campimeter chart showing centrocaecal scotoma in left eye
of case 19.
Fig 8.  photograph showing positive mantoux test (18mm) in case 19.
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Systemic features
Table-6
Systemic features Frequency Percent
Absent 13            65
Present 7 35
 Total 20 100.0
Systemic features were present in 7 cases (35%) and absent in 13 patients
(65%). One patient had fever and cerebellar ataxia, 6 patients had fever within 2
weeks before the onset of visual symptoms (Table-6).
Visual acuity at the time of presentation
Table-7
Visual acuity Frequency Percent
1/60 4 18.2
 2/60 1 4.5
4/60 1 4.5
6/60 5 22.7
6/36 5 22.7
6/24 3 13.6
6/18 3 13.6
Total 22 100.0
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Visual acuity at the time of presentation was 1/60 in 4 eyes (18.2%), 2/60
in 1 eye (4.5%), 4/60 in 1 eye (4.5%), 6/60 in 5 eyes(22.7%), 6/36 in 5
eyes(22.7%) 6/24 in 3 eyes(13.6%), 6/18 in 3 eyes (13.6%). The visual acuity was
better (6/18-6/24) in patients who presented late, a month after the onset of visual
symptoms (chart 5).
Time lag
Table-8
Time (days) Frequency Percent
0-14 4 20
15-21 13 65
More than 21 3 15
 The time interval between the onset of symptoms and initial presentation
at the hospital was between 2 to 3 weeks in 65% of cases, less than 2 weeks in
20% of cases, more than 3 weeks in 15% of cases. Range was between 10- 30
days with a mean value of 14.4 days (Table-8).
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Visual fields
Table -9
 Visual    fields Frequency Percent
Normal 2 9.10
Central scotoma 13 59.1
Centrocaecal scotoma 7 31.8
Total 22 100.0
Central fields were normal in 2 eyes of the same patient who presented 1
month after the onset of symptoms with features of resolution. Defective in 20
eyes (90.91%). All the patients had distortion of lines in amsler’s test, 13 eyes
(59.1%) had central scotoma, 7eyes (31.8) had centrocaecal scotoma (Table-9).
Visual acuity at 2 weeks
Table-10
V/A Frequency Percent
6/24 2 9.1
6/18 2 9.1
6/12 9 40.9
 6/9 6 27.3
 6/6 3 13.6
 Total 22 100.0
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Visual acuity improved 2 6/10 in 40.9% of eyes.6/9 in 27.30 % eyes  6/6 in
13.60% of eyes (table 10).
Visual fields at 2 weeks
Table -11
   Visual fields Frequency Percent
Normal 4 18.2
 Abnormal 18 81.8
Total 22 100.0
Visual fields examinations were normal in 4 eyes (18.2%), metamorphosia
was present in 18 eyes (81.8%) and central scotoma in 2 eyes in addition
(Table -11).
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Visual acuity at 4 weeks
Table 12
Visual acuity Frequency Percent
6/9 3 13.6
6/6 19 86.4
Total 22 100.0
Visual acuity improved to 6/9 in 3 eyes (13.6%), 6/6 in 19 eyes (86.4%) at
4 weeks follow-up (Table 12).
Visual fields at 4 weeks
Table 13
Visual fields Frequency Percent
Normal 19 86.4
abnormal 3 13.6
Total 22 100.0
Visual field was abnormal in3 eyes (13.6%) all 3 eyes had persistence of
metamorphosia (Table 13).
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Fundus at 4 weeks
Table 14
 Fundus examination Frequency Percent
Normal 6 22.27
Hard exudates+ 16 72.73
Total 22 100.0
 Fundus examination showed resolution of disc edema in all cases with
normal macula (without hard exudates) in 6 eyes (22.27%). Hard exudates were
present in 16 eyes (72.73%) at 4 weeks follow-up period (Table-14).
Hard exudates at 4 weeks on OCT
Table- 15
Exudates on OCT Frequency Percent
Absent 2 9.1
Present 20 90.9
 Total 22 100.0
Hard exudates were present in 20 eyes (90.9%), absent in 2 eyes (9.1%) at
4 weeks follow-up (Table-15).
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Optical Coherence Tomography
Central macular thickness at presentation
Table 16
V/A No. Mean Minimum Maximum
1/60 4 384.25 343 441
2/60 1 406.00 406 406
4/60 1 357.00 357 357
6/60 5 406.80 335 453
6/36 5 333.00 306 356
6/24 3 264.33 255 274
6/18 3 200.67 197 205
Total 22 336.09 197 453
OCT demonstrated flattening of the foveal contour, thickening of the
neuro-sensory retina, and accumulation of sub retinal fluid (SRF) in all studied
eyes. Retinal exudates appeared as multiple hyper-reflective foci in the outer
plexiform layer. The average central macular thickness was 336?m (range 197–
453?m) at presentation (chart 7).
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Foveal thickness - 4 weeks
Table 17
V/A N Minimum Maximum Mean
6/9 3 135 182 163.00
6/6 19 145 167 154.68
Total 22 135 182 155.82
At the end of 4 weeks OCT demonstrated average central macular
thickness of 155.82 µm with a range of 135 to 182µm and restoration of foveal
contour to normal in all cases (Table 17).
Analysis of Central macular thickness
Table-18
Foveal thickness N Minimum Maximum Mean
At the time of
presentation 22 197 453 336.09
At 2 weeks 22 147 267 193.36
At 4 weeks 22 135 182 155.82
Central macular thickness was in the range of 197-453 µm at the time of
presentation with a mean value of 336.09. At 2 weeks follow up minimum
thickness was 147µm and maximum was 267µm with mean of 193.36. Macular
thickness was in the range of 135-182 µm with a mean value of 155.82
(Table-18).
In CHI-Sq. Chart correlation between visual acuity and macular thickness
p value was 0.001 indicating in the difference in macular thickness is
significant(>0.01).
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INVESTIGATIONS
Table-19
      Investigation Frequency           Percent
Tuberculosis 3 15
IgM Toxoplasmosis 2 10
IgM CMV + TOXO 1 5
Normal 14 70
Total 20 100
In our study tuberculosis was positive in 3 cases (15%), IgM for
toxoplasmosis in 2 cases (10%), IgM CMV+TOXO positive in 1 case (5%). No
causative agent was identified in 14 cases (70%) (Table19).
TREATMENT
Table  -20
TREATMENT
NO OF
CASES
V/A AT 4 WKS
6/9 percent 6/6 Percent
STR+T.CIPRO 8 1 5 7 35
STR+C.DOX 8 1 5 7 35
STR+SYS.AB + SYS.AV 1 0 1 5
STR+ T.CIP+ATT 1 1 5 0 0
STR+C.DOX+ATT 2 0 0 2 10
total 3 15% 17 85%
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In the treatment group patients treated with Tab.Cipro visual acuity was
6/6 in 7 cases (35%), 6/9 in 1 case (5%). In patients treated with Cap.Doxy visual
acuity was 6/6 in 7 cases (35%), 6/9in 1 case (5%) (Table 20). Tuberculosis was
treated with antituberculous treatment in addition to steroids and oral antibiotics.
Patient with toxoplasmosis was treated with steroids undercover of Tab.
Azithromycin. Intravenous acyclovir was given in a patient with serological
evidence of CMV infection along with systemic antibiotics.
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DISCUSSION
1. AGE
In this study 22 eyes of 20 patients were examined. Majority of the
patients belonged to 30 to 40 years of age group. The minimum age of onset was
7 years and maximum age was 57 years with a mean of 33.55 years.
Glaser JS: Neuro-ophthalmology. Hagers-town, Md, Harper & Row
Publishers Inc, 1978, vol 10, p 85 showed that neuroretinitis is more common in
3rd to 4th decade.
Chi SL, stinnett S, Duke eye center and Duke university medical centre,
American Academy of Ophthalmology Sep 2011, have shown that in their study
of 53 patients with neuroretinitis, the mean age of onset was 28.5 years with a
range of 8-65 years.
2. SEX
In our study 9 females (45%), 9 males (45%) and 2 children (10%) were
affected. The female to male ratio was 1:1.
Glaser JS: Neuro-ophthalmology. Hagers- town, Md, Harper & Row
Publishers Inc, 1978, vol 10, p 85 have also shown similar findings in their study
with no gender predilection.
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3. LATERALITY
Right eye was affected in 9 cases (45%), left eye in 9 cases (45%) and both
eyes in 2 cases (10%).
Carroll DM, Franklin RM. Leber’s idiopathic stellate retinopathy,.
Am J Ophthalmol 1982; 93: 96-101 shown that most of the cases were unilateral.
Chi SL, stinnett S, Duke eye center and Duke university medical centre,
American Academy of Ophthalmology Sep 2011, in their study of 53 patients
observed that 83% of cases were unilateral and 17% of cases were bilateral.
4. ETIOLOGY OF NEURORETINITIS
The etiology of neuroretinitis in our study was infection in 30% of cases.
Tuberculosis (15%), toxoplasmosis (10%) constituted the majority of cases.70%
of cases were idiopathic in etiology.
Walsh FB, Hoyt WF. Neuroretinitis. In: Clinical neuro-ophthalmology.
3 rd ed. Baltimore, Md: Williams and Wilkins Co; 1982. p. 234-5.
The etiopathology of neuroretinitis is obscure. Neuroretinitis is thought to
be an infectious or immune-mediated process that may be precipitated by a
number of different agents. Commonly associated with an antecedent viral
syndrome, in up to 50% of the cases, viruses are seldom cultured from vitreous
and aqueous humor and CSF of such patients, and the serological evidence of a
concomitant viral infection is usually lacking. Proposed causative viral agents
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include herpes simplex, hepatitis B, mumps and the herpes viruses associated
with the acute retinal necrosis syndrome. Other common infections that cause
neuroretinitis are CSD, spirochetosis especially syphilis, Lyme disease and
leptospirosis. Presumed etiologies for neuroretinitis also include toxoplasmosis,
toxocariasis and histoplasmosis.
5. TREATMENT OF NEURORETINITIS
In our study all the patients received high dose intravenous bolus methyl
prednisolone along with oral antibiotics. Systemic antibiotics, antiviral drugs
were given depending upon the etiology.
Ghuari, Lee A, Optic disc edema with a macular star, Survey of
Ophthalmology 43(3); 270-274, 1998.
Purvin V, Sundarm S, Kawasaki A, Neuroretinitis: review of the literature
and new observations J. Neuro-ophthalmology 31: 58-68; 2011
Treatment of neuroretinitis is directed underlying etiology. Tuberculosis
requires consultation with an infectious disease specialist. If an infectious
etiology is suspected appropriate workup with broad-spectrum antibiotic is
started. Treatment includes observation, bolus intravenous steroids, steroid with
antibiotic, steroids only.
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6. VISUAL ACUITY AT PRESENTATION
In our study visual acuity at presentation was between 1/60 t0 6/18. Visual
acuity at the time of presentation was 1/60 in 4 eyes (18.2%), 2/60 in 1 eye
(4.5%), 4/60 in 1 eye(4.5%), 6/60 in 5 eyes(22.7%), 6/36 in 5 eyes(22.7%) 6/24 in
3 eyes(13.6%), 6/18 in 3 eyes (13.6%). The visual acuity was better (6/18-6/24) in
patients who presented late, a month after the onset of symptoms.
Dreyer RF,  Hopen G, Gass JDM, Smith JL: Leber’s idiopathic stellate
neuroretinitis. Arch Ophthalmol 1984; 102: 1140-45 showed that the Visual
acuity at presentation can range from 6/6 to light perception.
Chi SL, stinnett S, Duke eye center and Duke university medical centre,
American Academy Ophthalmology Sep 2011, study on clinical characteristics of
cat scratch neuroretinitis showed that visual acuity at presentation ranged from
6/6 to counting fingers.
7. VISUAL ACUITY AT 4 WEEKS
Visual acuity improved to 6/6 in 19 eyes (86.4%), 6/9 in 3 eyes (13.6%) at
4 weeks follow-up period. Patients with final visual acuity of 6/9 at presentation
had vision of 1/60, 2/60, 4/60 and presented at 20, 14, 20 days respectively.
Dreyer RF, Hopen G, Gass JDM, Smith JL: Leber’s idiopathic stellate
neuroretinitis. Arch Ophthalmol 1984; 102: 1140-45 observed that 26 of 27
patients  recovered vision of 6/12 or better within 2 months follow-up.
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8. FUNDUS EXAMINATION AT 4 WEEKS
Fundus examination showed resolution of disc edema in all cases with
normal macula (without hard exudates) in 6 eyes (27.3%). Hard exudates were
present in 16 eyes (72.7%) at 4 weeks follow-up period.
Dreyer RF, Hopen G, Gass JDM, Smith JL: Leber’s idiopathic stellate
neuroretinitis. Arch Ophthalmol 1984; 102: 1140-45 showed that over 6 to 8
weeks,the optic disc swelling resolves, and the appearance of the disc becomes
normal or mildly pale. The macular exudates appear late and progress over about
7 to 10 days, then remain stable for several weeks before gradual resolution
occurs over 6 to 12 months.
9. OPTICL COHERENCE TOMOGRAPHY EXAMINATION
OCT demonstrated flattening of the foveal contour, thickening of the
neuro-sensory retina, and accumulation of sub retinal fluid (SRF) in all studied
eyes. Retinal exudates appeared as multiple hyper-reflective foci in the outer
plexiform layer. The average central macular thickness was 336?m
(range 197–453?m) at presentation. The macula appeared normal in contour on
repeated exams during follow-up and presence of hard exudates in 17 eyes
(77.27%).
Macular findings on optical coherence tomography in cat-scratch disease
neuroretinitis; Z Habot-Wilner, D Zur, M Goldstein, D Goldenberg, S Shulman,
A Kesler, M Giladi and M Neudorfer
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Eight eyes of seven patients with confirmed CSD neuroretinitis, mean age
33±9.9 years, range (6–48 years) were included in the study. All patients
presented clinically with optic nerve swelling and macular edema or macular
exudates. OCT demonstrated flattening of the foveal contour, thickening of the
neurosensory retina, and accumulation of subretinal fluid (SRF) in all studied
eyes. Retinal exudates appeared as multiple hyper-reflective foci in the outer
plexiformlayer. The average central macular thickness was 460?m (range
170–906?m) and the average maximal retinal thickness was 613?m (range 387–
1103?m), at presentation. The macula appeared normal on repeated scans during
follow-up.
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Case 1
Fig 9.Fundus photograph showing Fig 10. OCT picture showing
macular star and disc edema. serous retinal detachment
Fig 11 Fundus photograph Fig 12. OCT picture showing
showing resolution of disc edema resolution of serous detachment
and  macular star. and presence of  hard exudates.
Hard exudates
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CASE 6
Fig.13 Fundus photograph of Fig.14  OCT Picture showing
patient 1 showing disc edema, small serous retinal detachement
macular star
Fig.15 Fundus photograph Fig.16 OCT picture showing
showing resolution of disc resolution of serous detachment
edema and persistence of and presence of hard exudates
macular star.
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CASE 19
Fig.17 Fundus photograph showing Fig .18 OCT picture showing small sub
disc edema with macular star foveal serous detachment of macula
Fig 19 Fundus photograph showing  Fig 20 OCT picture showing
resolution  of hard exudates and resolution  of serous detachment
disc edema at 4 weeks. and prominence of hard exudates.
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CONCLUSION
To conclude in our study the following  observations were made
1. Neuroretinitis was more common between 3rd to 4th decades of life.
2. Males and females were equally affected.
3. Presentation was unilateral in most of the cases.
4. Bilateral presentation was common in children.
5. Bilateral presentation was most likely to be associated with an infectious
etiology.
6. In adults with systemic manifestations, infectious etiology should be ruled out.
7. Presenting visual acuity was between 6/60 and 6/36 in 45.4% of patients.
8. Visual acuity was 6/24 or better in patients who presented late during the
course of illness suggesting spontaneous recovery.
9. All the patients had final visual acuity of 6/9 or better.
10.  Metamorphosia was present in 90.91% of patients at the time of presentation.
11. Central and centrocaecal scotoma was the commonest visual field defect
encountered.
12.  Metamorphosia resolved in 95% of patients.
13.   Central and centrocaecal field defects resolved in all patients.
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14.  Pupil showed relative afferent pupillary defect in 91% of eyes at the time of
presentation.
15.  RAPD improved with visual improvement.
16.   Colour vision was defective in 91% of eyes
17.  Colour vision returned to normal in all cases.
18.  Macular edema was observed as early as 5 days.
19.  Hard exudates were present in the macula as early as 7 days after the onset of
visual symptoms.
20.   Disc edema started resolving with appearance of hard exudates in macula
and was complete at 4 weeks.
21.  Visual acuity and field defects improved with the resolution of macular
edema suggesting that macular edema was the cause of defective vision and
field defects.
22.   Neuroretinitis was idiopathic in etiology in 70% of patients.
23. Tuberculosis and Toxoplasmosis was the common infectious agent in 25% of
patients.
24.  Visual improvement was faster when treated with steroids and antibiotics
25. No significant difference in final visual acuity on treatment with either Tab.
Cipro or Cap .Doxy.
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26. Optical coherence tomography of macula showed serous macular detachment
in all cases
27.  OCT demonstrated flattening of the foveal contour, thickening of the neuro-
sensory retina, and accumulation of sub retinal fluid (SRF) in all studied eyes.
Retinal exudates appeared as multiple hyper-reflective foci in the outer
plexiform layer.
28.    Improvement in visual acuity was associated with resolution of macular
edema on fundoscopy and reduction of macular thickness on OCT.
29.  Hard exudates became more prominent with resolution of macular edema and
resolution of disc edema.
30. Hard exudates were present on fundus examination in 72% of cases at 4 weeks
follow up. OCT demonstrated hard exudates in 91% of cases.
31.  Reduction of macular edema correlated well with improvement in visual
acuity rather than resolution of hard exudates.
32.  Persistence of metamorphosia in some cases may be due to persistence of
hard exudates at macula demonstrated well on OCT.
33. Macular thickness on OCT correlated well with visual acuity. Greater the
central macular thickness poorer the visual acuity. OCT is an adjuvant tool in
management of neuroretinitis.
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LIMITATION OF THE STUDY
Due to Economic constraints ELISA for Toxocara and Bartonella were not
done in our study.
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PROFORMA
STUDY OF THE CLINICAL COURSE AND OPTICAL COHERENCE
TOMOGRAPHY ANALYSIS OF MACULAR THICKNESS IN
NEURORETINITIS
NAME: CASE NO:
AGE   : IP/OP NO:
SEX    : DATE:
OCCUPATION:                                                CONTACT NO:
ADDRESS:
COMPLAINTS
Defective vision / visual field loss / distortion of objects / fever / orbital or
ocular pain / pain on eye movement / fever / headache / nausea / vomiting.
Visual disturbances - unilateral/ bilateral, onset, duration,
progressive/static/ recovering
HISTORY
Fever / malaise/ cough/ cold/ joint pain/ exanthematous illness/ skin
rashes/ ENT sepsis/ dental sepsis/ loss of weight/ loss of apetite / chest pain/
seizures/ neck stiffness/  tick bite/ recent travel
Contact with tuberculosis
Contact with pet animals
Consumption of undercooked food
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PAST HISTORY
Similar Episodes/ Hypertension / Diabetes Mellitus / Tuberculosis /
Syphilis/ HIV / Exanthematous Fever / Connective Tissue Disorder / Endocrine
Disorders / Malignancy.
FAMILY HISTORY
Similar disease in the family members
GENERAL EXAMINATION
Pulse: B.P: Respiratory rate:
Temperature
Anemia
Lymphadenopathy
Focal sepsis
Mastoid Tenderness
Skin rashes
OPHTHALMIC EXAMINATION
Head Posture
Facial Symmetry
Laterality RE LE
Eye Position
Eye lids
Ocular movements
Conjunctiva
Cornea
Anterior chamber
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Iris
Pupil
1. Size
2. Shape
3. Light reflex
a) Direct
b) Consensul
c) Near reflex
Lens
Anterior vitreous phase
FUNDUS BOTH DIRECT & INDIRECT
Media
Disc
Macula
Vessels
Periphery
Best Corrected Visual Acuity
                         Distant
                         Near
Colour vision
Retinoscopy
Intraocular tension (NCT)
Visual fields
               Central
               Peripheral
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Fundus photograph
Optical Coherence Tomography of macula
                   Line Scan
                   Macula Thickness Map
SYSTEMIC EXAMINATION
 Cardiovascular System
 Respiratory System
 Gastrointestinal System
 Genitourinary system
 E.N.T Examination
Central nervous system
PROVISIONAL DIAGNOSIS
INVESTIGATIONS
Hematology:
Hb% TC  DC ESR
Mantoux test                                    Chest X Ray
Blood VDRL                                     ELISA
TORCHES SCREENING
Blood sugar- Fasting, Post prandial
C.S.F analysis (if any)
Urine – Albumin Sugar                          Motion – Ova Cyst
MRI brain if needed
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FINAL DIAGNOSIS:
TREATMENT GIVEN:
 FOLLOW UP:
    AT 2 WEEKS RE                              LE
                      Visual acuity (BCVA)
                      Pupillary assessment
                      Colour vision
                      Visual fields
                      Fundus examination
                      Fundus photograph
                      Optical Coherence Tomography
AT 4 WEEKS: RE                                LE
                      Visual acuity (BCVA)
                      Pupillary assessment
                      Colour vision
                      Visual fields
                      Fundus examination
                      Fundus photograph
                      Optical Coherence Tomography
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KEY TO MASTER CHART
M - Male
F - Female
R - Right eye
L - Left eye
SF - Systemic Features
1 - absent
2 - Present
V/A - Visual Acuity
Pupil
1 - Normal
2 - RAPD
RAPD - Relative afferent Pupillary Defect
CV - Colour Vision
1 - Normal
2 - Defective
V/F - Visual Field
1 - Normal
2 - Abnormal
75
FUN - Fundoscopy
1 - Normal
2 - Abnormal
OCT - Optical Coherence Tomography
HE - Hard Exudates
1 - absent
2 - Present
INV - Investigation
1 - NEGATIVE
2 - TB
3 - IgM CMV+
4 - IgM toxo+
TREAT - Treatment
1 -  STR
2 - T.CIP
3 - C.DOX
4 - SYSTEMIC ANTIBIOTIC
5 - SYSTEMIC ANTIVIRAL
6 - ATT
V/A TIME PUPIL CV V/F FUN OCT HE V/A PUPIL CV V/F FUN OCT HE V/A PUPIL CV V/F FUN OCT HE
1 Eganathan 234894 m 30 L 1 6|24 30days 2 2 2 2 255 2 6|9 1 1 1 2 176 2 6|6 1 1 1 1 157 2 1 1+2
2 Vinayagam 464105 m 35 R 1 6|36 15 days 2 2 2 2 306 2 6|12 2 2 2 2 189 2 6|6 1 1 1 2 148 2 1 1+3
3 Naseema 340862 f 31 R 1 6|18 20 days 2 2 2 2 200 2 6|9 1 1 2 2 147 2 6|9 1 1 1 2 145 1 1 1+2
4 Nagammmal 457277 f 31 L 1 6|60 10 days 2 2 2 2 335 2 6|12 2 2 2 2 198 2 6|6 1 1 2 2 153 2 1 1+3
5 Kumari 652331 f 45 L 1 6|36 20 days 2 2 2 2 321 2 6|12 2 2 1 2 191 2 6|6 1 1 1 2 162 2 1 1+2
6 Velmuugan 761160 m 38 L 2 2|60 14 days 2 2 2 2 406 2 6|24 2 2 2 2 267 2 6|9 1 1 1 2 172 2 2 1+3+6
7 Baskaran 962568 m 35 R 1 1|60 10 days 2 2 2 2 396 2 6|9 1 1 2 2 177 2 6|6 1 1 1 2 152 2 1 1+2
8 Jessigrace 161906 f 57 L 1 1|60 20 days 2 2 2 2 343 2 6|18 2 2 2 2 180 2 6|6 1 1 2 2 135 2 1 1+3
9 Pasupathy 272521 m 7 R 2 6|18 30days 2 3 1 2 197 2 6|6 1 1 1 2 148 2 6|6 1 1 1 1 148 1 3+4 1+4+5
9 Pasupathy 272521 m 7 L 2 6|18 30days 2 3 1 2 205 2 6|6 1 1 1 2 159 2 6|6 1 1 1 1 159 1 3+4 1+4+5
10 Sambath 311016 m 29 L 2 1|60 10days 2 2 2 2 453 2 6|18 2 2 2 2 227 2 6|6 1 1 1 2 167 2 4 1+4
11 Kalyani 337814 f 42 R 2 6|60 14 days 2 2 2 2 389 2 6|12 2 2 2 2 197 2 6|6 1 1 1 2 154 2 1 1+3
12 Radha bai 452194 f 35 R 1 6|36 18 days 2 2 2 2 356 2 6|9 2 1 2 2 188 2 6|6 1 1 1 2 164 2 1 1+2
13 Shenbagam 571069 f 38 R 1 4|60 12days 2 2 2 2 357 2 6|24 2 2 2 2 231 2 6|6 1 1 2 2 182 2 1 1+3
14 Surya 790682 m 40 L 1 6|24 20days 2 2 2 2 264 2 6|6 1 1 2 2 164 2 6|6 1 1 1 1 149 2 1 1+2
15 Vasantha 821195 f 32 R 1 6|36 15 days 2 2 2 2 354 2 6|12 2 2 2 2 195 2 6|6 1 1 1 2 155 2 1 1+3
16 Mohan 146146 m 37 L 2 6|60 10days 2 2 2 2 412 2 6|12 2 2 2 2 207 2 6|9 1 1 1 2 159 2 2 1+2+6
17 Kesavan 364934 m 33 R 1 6|36 15days 2 2 2 2 328 2 6|9 1 1 2 2 192 2 6|6 1 1 1 2 152 2 1 1+3
18 Alagammal 478563 f 37 R 1 6|60 30days 2 2 2 2 274 2 6|12 1 1 2 2 187 2 6|6 1 1 1 2 148 2 1 1+2
19 Ambika 542548 f 27 L 2 1|60 15 days 2 2 2 2 432 2 6|12 2 2 2 2 199 2 6|6 1 1 1 2 156 2 2 1+3+6
20.A Karthik 668456 m 12 R 2 6|24 20days 2 3 2 2 351 2 6|9 2 2 2 2 165 2 6|6 1 1 1 1 152 2 4 1+5
20.B Karthik 668456 m 12 L 2 6|24 20days 2 3 2 2 367 2 6|9 2 2 2 2 174 2 6|6 1 1 1 1 159 2 4 1+5
S.
 NO Name MRD NO SEX AGE EYE S.F INV TREAT
ON PRESENTATION AT 2 WEEKS AT 4 WEEKS
